Development of new-type radiommunoassay system with higher sensitivity and lower radioactive waste disposal.

开发灵敏度更高、放射性废物处理更少的新型放射免疫分析系统。

基本信息

  • 批准号:
    04557049
  • 负责人:
  • 金额:
    $ 4.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1994
  • 项目状态:
    已结题

项目摘要

To achieve higher sensitivity in the detection of biologically active substances (ca..antibodies, drugs, antisense oligonucleotides, etc.) and lessen radioactive waste disposal, short-lived gamma emitting metal radionuclide was attached to such molecules. Gallium-67(Ga-67, half life=78hr)or indium-111 (In-111, half life=2.8day) was selected as a metalradionuclide and biologically active substances conjugated with deferoxamine, diethylenetriamine-pentaacetic acid or isothiocyanobenzyl-EDTA were radiolabeled.(1) Antibody : monoclonal anti-human growth hormone (GH) antibody was conjugated with deferoxiamine (DF) through dialdehyde-starch polymer spacer and labeled with Ga-67. Using this Ga-67-anti-GH antibody, immunoradiometric assay with 10 times higher sensitivity could be realized.(2) Drug : digoxin, a cardiac glycoside requireing therapeutic drug monitoring, was labeled with Ga-67 using DF as a bifunctional chelating agent. Ga-67-DF-digoxin has similar affinity to anti-digoxin antibody as well as Na, K-ATPase. Using the Ga-67-DF-digoxin, digoxin-RIA as well as myocardial Na, K-ATPase imaging in vivo.were successfully performed.3) Antisense oligonucleotide : Antisense oligonucleotide against human c-erbB-2 was 5'-aminated and conjugated with isothiocyanobenzyl-EDTA (IBE) and labeled with In-111. In-111-IBE-oligonucleotide showed high stability even in human serum, an indication of possible in-vivo application. In fact, biodistribution study in nude mice bearing c-erbB2 mRNA (+) tumor indicated the sequence selective tumor localization.It was concluded that short-lived metal radionuclide can be used not only for in vivo nuclear medicine, but in vitro diagnosis as well as basic research studies.
为了在生物活性物质的检测中达到更高的灵敏度(ca…抗体、药物、反义寡核苷酸等)和减少放射性废物的处置,短寿命的伽马发射金属放射性核素被附着在这类分子上。选择镓-67(Ga-67,半衰期为78小时)或铟-111 (In-111,半衰期为2.8天)作为金属放射性核素,并对与去铁胺、二乙烯三胺-五乙酸或异硫氰苄酶- edta偶联的生物活性物质进行放射性标记。(1)抗体:单克隆抗人生长激素(GH)抗体通过二醛-淀粉聚合物间隔剂与去铁胺(DF)偶联,用Ga-67标记。使用该ga -67抗gh抗体,可实现灵敏度提高10倍的免疫放射测定。(2)药物:地高辛是一种需要治疗药物监测的心脏糖苷,使用DF作为双功能螯合剂,用Ga-67标记。ga -67- df -地高辛与抗地高辛抗体和Na, k - atp酶具有相似的亲和力。采用ga -67- df -地高辛、地高辛- ria以及心肌Na、k - atp酶在体显像。执行成功。3)反义寡核苷酸:抗人c-erbB-2的反义寡核苷酸经5′胺化,与异硫氰酸obase - edta (IBE)偶联,用In-111标记。in- 111- ibe寡核苷酸即使在人血清中也表现出很高的稳定性,表明可能在体内应用。事实上,在携带c-erbB2 mRNA(+)肿瘤的裸鼠中的生物分布研究表明,序列选择性肿瘤定位。结果表明,短寿命金属放射性核素不仅可用于体内核医学,还可用于体外诊断和基础研究。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Takemura, Y.Fujibayashi, et al: "Development of glycoside-bound radiopharmaceuticals : novel radioiodination method for digoxin." Biological & Pharmaceutical Bulletin. 17. 97-101 (1994)
Y.Takemura、Y.Fujibayashi 等人:“糖苷结合放射性药物的开发:地高辛的新型放射性碘标记方法。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y. Fujibayashi, H. Taniuchi, et al.: "Differential retention mechanism of Cu-pyruvaldehyde bis (N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor. A novel radiopharmaceutical for positron emission tomography imaging." Annals of Nuclear. Medicine. (
Y. Fujibayashi、H. Taniuchi 等人:“大脑和肿瘤对 Cu-丙酮醛双 (N4-甲硫缩氨基脲) (Cu-PTSM) 的差异保留机制。一种用于正电子发射断层扫描成像的新型放射性药物。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Fujibayashi,et al.: "Basic evaluation of Ga-67-labeled digoxin derivative as a metallabeled bifunctional radiopharmaceutical." Annals of Nuclear Medicine. 7. 239-244 (1993)
Y.Fujibayashi 等人:“Ga-67 标记的地高辛衍生物作为金属标记的双功能放射性药物的基本评估”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Takemura,Y.Fujibayashi,et al.: "Development of glycoside bound radiopharmaceuticals:novel radioiodination method for sigoxin." Biological & Pharmaceutical Bulletin. 17. 97-101 (1994)
Y.Takemura,Y.Fujibayashi,等人:“糖苷结合放射性药物的开发:西戈辛的新型放射性碘标记方法。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
松本 和也: " Cu-labeled bifunctional Radiopharmaceutical with metabolic ester groups." Nucl.Med.Biol.19. 33-38 (1992)
Kazuya Matsumoto:“具有代谢酯基团的铜标记双功能放射性药物。”Nucl.Med.Biol.19(1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJIBAYASHI Yasuhisa其他文献

FUJIBAYASHI Yasuhisa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJIBAYASHI Yasuhisa', 18)}}的其他基金

Research on a new internal radiation therapy agent targeting for hypoxic tumors.
针对缺氧肿瘤的新型体内放射治疗剂的研究。
  • 批准号:
    14370274
  • 财政年份:
    2002
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of brain/heart pathogenesis based on mitochondiral function and its application to nuclear medicine.
基于线粒体功能的脑/心脏发病机制分析及其在核医学中的应用。
  • 批准号:
    11670882
  • 财政年份:
    1999
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research on the diagnosis and therapy for abnormal brain aging caused by oxidative stress.
氧化应激引起的脑异常衰老的诊断和治疗的基础研究。
  • 批准号:
    09670930
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Automated microfluidic production of high specific activity PET tracers to enable routine CNS imaging
自动微流体生产高比活性 PET 示踪剂,以实现常规 CNS 成像
  • 批准号:
    8870224
  • 财政年份:
    2015
  • 资助金额:
    $ 4.22万
  • 项目类别:
Automated microfluidic production of high specific activity PET tracers to enable routine CNS imaging
自动微流体生产高比活性 PET 示踪剂,以实现常规 CNS 成像
  • 批准号:
    9060851
  • 财政年份:
    2015
  • 资助金额:
    $ 4.22万
  • 项目类别:
High specific activity radioisotopes
高比活度放射性同位素
  • 批准号:
    386567-2010
  • 财政年份:
    2014
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Discovery Grants Program - Individual
High specific activity radioisotopes
高比活度放射性同位素
  • 批准号:
    386567-2010
  • 财政年份:
    2013
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Discovery Grants Program - Individual
High Specific Activity Medical Isotopes via Electromagnetic Mass Separation
通过电磁质量分离获得高比活度医用同位素
  • 批准号:
    442600-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
High specific activity radioisotopes
高比活度放射性同位素
  • 批准号:
    386567-2010
  • 财政年份:
    2012
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Discovery Grants Program - Individual
Microliter radiosynthesizer for producing high specific activity PET ligands
用于生产高比活性 PET 配体的微升放射合成仪
  • 批准号:
    8508266
  • 财政年份:
    2012
  • 资助金额:
    $ 4.22万
  • 项目类别:
Microliter radiosynthesizer for producing high specific activity PET ligands
用于生产高比活性 PET 配体的微升放射合成仪
  • 批准号:
    8355063
  • 财政年份:
    2012
  • 资助金额:
    $ 4.22万
  • 项目类别:
High specific activity radioisotopes
高比活度放射性同位素
  • 批准号:
    386567-2010
  • 财政年份:
    2011
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Discovery Grants Program - Individual
High specific activity radioisotopes
高比活度放射性同位素
  • 批准号:
    386567-2010
  • 财政年份:
    2010
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了